SAGE-718 Fails Phase 2 Study, Foralumab Dampens Microglial Activation, MDA and FARA Collaborate on G...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_3047478593

SAGE-718 Fails Phase 2 Study, Foralumab Dampens Microglial Activation, MDA and FARA Collaborate on Gene Therapy Studies

Full title

SAGE-718 Fails Phase 2 Study, Foralumab Dampens Microglial Activation, MDA and FARA Collaborate on Gene Therapy Studies

Publisher

Cranbury: Intellisphere, LLC

Journal title

Neurology live (Print), 2024-04

Language

English

Formats

Publisher

Cranbury: Intellisphere, LLC

Subjects and topics

Full title

SAGE-718 Fails Phase 2 Study, Foralumab Dampens Microglial Activation, MDA and FARA Collaborate on Gene Therapy Studies

Record Identifier

TN_cdi_proquest_reports_3047478593

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_3047478593

ISSN

2767-4258

E-ISSN

2767-4266

Log in as a Library member

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning programs and resources linked to the curriculum.

Showcasing people, places and ideas inspired by the collection and the library community.